![Hartmut Juhl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hartmut Juhl
Vorstandsvorsitzender bei Indivumed GmbH
Profil
Hartmut Juhl is the founder.
He founded Indivumed GmbH in 2002 and currently holds the title of Chief Executive Officer.
In addition to his founding position, Dr. Juhl also worked as an Associate Professor at Georgetown University.
He obtained a doctorate degree from the University of Hamburg.
Aktive Positionen von Hartmut Juhl
Unternehmen | Position | Beginn |
---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Vorstandsvorsitzender | 01.04.2002 |
Ehemalige bekannte Positionen von Hartmut Juhl
Unternehmen | Position | Ende |
---|---|---|
Georgetown University | Corporate Officer/Principal | - |
Ausbildung von Hartmut Juhl
University of Hamburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |